StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
86
This month
3
This year
12
Publishing Date
2024 - 03 - 06
2
2024 - 01 - 04
2
2023 - 08 - 10
1
2023 - 07 - 27
1
2023 - 07 - 11
1
2023 - 06 - 16
1
2023 - 06 - 08
1
2023 - 05 - 26
1
2023 - 05 - 23
1
2023 - 05 - 10
1
2023 - 05 - 09
1
2023 - 05 - 03
2
2023 - 04 - 21
1
2023 - 04 - 06
1
2023 - 04 - 03
1
2023 - 03 - 23
1
2023 - 03 - 16
1
2023 - 03 - 13
1
2023 - 02 - 21
1
2023 - 02 - 07
1
2023 - 01 - 25
1
2022 - 12 - 28
1
2022 - 12 - 19
1
2022 - 12 - 09
2
2022 - 12 - 01
1
2022 - 11 - 07
1
2022 - 11 - 04
1
2022 - 11 - 02
2
2022 - 10 - 20
3
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 22
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
Sector
Distribution services
1
Finance
6
Finance and insurance
4
Health technology
86
Tags
Alzheimer
1
America
1
Aml
1
Antibody
2
Asco
1
Biotech
1
Blood
1
Breast
1
Business
8
Cancer
6
Candidate
2
Cell
3
Change
1
Clearance
1
Clinical-trials-phase-ii
5
Clinical-trials-phase-iii
2
Collaboration
2
Companies
1
Conference
21
Designation
1
Disease
1
Drug
3
Earnings
10
Europe
13
Events
22
Expansion
1
Fast track designation
1
Fda
2
Financial
11
Financial results
1
First
1
Genetic
1
Global
1
Growing
1
Iph45
2
Iph5201
2
Iph6101
4
Market
3
Money
2
N/a
4
Natural
4
News
4
Pharma
76
Pharmaceutical
14
Phase 2
4
Platform
2
Preclinical
3
Program
3
Regulatory
5
Report
6
Research
3
Results
14
Sanofi
6
Study
4
Therapeutics
4
Treatment
2
Trial
5
Universal
2
Update
15
Year
4
Entities
Abbvie inc.
1
Affimed n.v.
2
Amgen inc.
1
Aptorum group limited
1
Astrazeneca plc
4
Biontech se
1
Bnp paribas
4
Denali therapeutics inc.
2
Fate therapeutics, inc.
1
Gilead sciences, inc.
1
Immunogen, inc.
1
Innate pharma s.a.
80
Innate pharma sa
86
Morgan stanley
1
Myriad genetics, inc.
1
Nkarta, inc.
1
Novo nordisk a/s
44
Pfizer, inc.
1
Replimune group, inc.
1
Sanofi
81
Sensient technologies corporation
1
Svb financial group
1
Takeda pharmaceutical company limited
1
Trinity biotech plc
1
Verona pharma plc
1
Viatris inc.
1
Symbols
AAPL
1198
ABB
1210
ABBV
612
ABLZF
1172
ABT
1082
ACAQ
522
AMGN
744
AMSIY
468
AMSYF
468
ARCXF
468
ARVL
4308
AVGO
597
AZN
667
BNPQF
1767
BNPQY
1767
CRCW
473
CSCO
900
DNZOF
504
DNZOY
504
ERIC
1614
EXTR
581
FNCTF
7217
FRBA
600
GE
509
GILD
500
GLAXF
661
GOOG
1295
GOOGL
1294
GSK
814
HON
1029
IFNNF
533
IFNNY
511
INTC
955
JNJ
2081
LLY
1089
LTUM
972
MAR
476
MDT
732
MS
1791
MSFT
1203
MT
476
NIPNF
533
NOK
862
NOKBF
980
NVDA
519
NVS
1159
NVSEF
1034
ORCL
787
PCRFF
651
PCRFY
651
PHG
477
PPRUF
1131
PPRUY
1132
SAP
1382
SAPGF
1234
SNY
4551
SNYNF
3609
TEVJF
632
TMO
709
VSAC
534
Exchanges
Nasdaq
86
Nyse
48
Crawled Date
2024 - 03 - 06
2
2024 - 01 - 04
2
2023 - 08 - 10
1
2023 - 07 - 27
1
2023 - 07 - 11
1
2023 - 06 - 16
1
2023 - 06 - 08
1
2023 - 05 - 26
1
2023 - 05 - 23
1
2023 - 05 - 10
1
2023 - 05 - 09
1
2023 - 05 - 03
2
2023 - 04 - 21
1
2023 - 04 - 06
1
2023 - 04 - 03
1
2023 - 03 - 23
1
2023 - 03 - 16
1
2023 - 03 - 13
1
2023 - 02 - 21
1
2023 - 02 - 07
1
2023 - 01 - 25
1
2022 - 12 - 28
1
2022 - 12 - 19
1
2022 - 12 - 09
2
2022 - 12 - 01
1
2022 - 11 - 07
1
2022 - 11 - 04
1
2022 - 11 - 02
2
2022 - 10 - 20
3
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 22
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
Crawled Time
06:00
4
07:00
21
08:00
18
09:00
19
10:00
9
11:00
8
12:00
3
12:30
1
13:00
2
18:00
1
Source
www.biospace.com
82
www.globenewswire.com
1
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
IPHYF
exchanges :
Nasdaq
save search
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published:
2024-04-10
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.64%
|
O:
-0.32%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-6.92%
|
O:
-3.85%
H:
1.2%
C:
0.8%
iph45
pharma
drug
candidate
antibody
preclinical
Innate Pharma Announces Its Participation in Upcoming April 2024 Investor Conference
Published:
2024-04-09
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.38%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.21%
|
O:
-0.38%
H:
0.95%
C:
0.83%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-2.81%
|
O:
2.57%
H:
1.81%
C:
1.81%
pharma
conference
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published:
2024-04-05
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.54%
|
O:
-1.77%
H:
0.0%
C:
-1.81%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.77%
|
O:
-3.44%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-3.2%
|
O:
-0.4%
H:
0.0%
C:
-5.22%
pharma
report
universal
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published:
2024-03-21
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.21%
|
O:
0.3%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-3.2%
|
O:
-4.51%
H:
4.25%
C:
0.96%
pharma
business
year
update
financial
results
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published:
2024-03-19
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.31%
|
O:
-0.02%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.65%
|
O:
-1.51%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
1.26%
|
O:
0.84%
H:
4.56%
C:
0.83%
pharma
conference
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published:
2024-03-14
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.23%
|
O:
0.23%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-3.2%
|
O:
-2.4%
H:
3.69%
C:
3.28%
pharma
conference
year
financial
results
Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
Published:
2024-03-06
(Crawled : 12:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.68%
|
O:
-0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-5.84%
|
O:
0.78%
H:
1.93%
C:
0.97%
iph6501
first
study
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published:
2024-03-06
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.68%
|
O:
-0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-5.84%
|
O:
0.78%
H:
1.93%
C:
0.97%
iph45
pharma
drug
antibody
preclinical
Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published:
2024-02-21
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.49%
|
O:
1.7%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.37%
|
O:
-0.57%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-6.56%
|
O:
-2.32%
H:
0.0%
C:
0.0%
pharma
conference
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published:
2024-01-12
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-11.92%
|
O:
0.71%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-11.59%
|
O:
0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-13.26%
|
O:
0.0%
H:
0.36%
C:
0.36%
pharma
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Published:
2024-01-04
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.51%
|
O:
1.62%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-7.56%
|
O:
1.12%
H:
0.93%
C:
0.77%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-12.95%
|
O:
6.47%
H:
3.65%
C:
-2.36%
pharma
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published:
2024-01-04
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.51%
|
O:
1.62%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-7.56%
|
O:
1.12%
H:
0.93%
C:
0.77%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-12.95%
|
O:
6.47%
H:
3.65%
C:
-2.36%
fda
pharma
program
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
26.55%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.49%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-1.22%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Innate Pharma Announces Leadership Change - December 18, 2023
Published:
2023-12-18
(Crawled : 10:00)
- biospace.com/
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.29%
|
O:
1.25%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
0.41%
|
O:
2.9%
H:
2.02%
C:
-1.21%
pharma
change
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published:
2023-12-11
(Crawled : 08:00)
- biospace.com/
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
11.81%
|
O:
9.45%
H:
0.0%
C:
-1.7%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.54%
|
O:
0.5%
H:
1.67%
C:
0.1%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.14%
|
O:
2.15%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-6.2%
|
O:
-1.16%
H:
0.39%
C:
-4.31%
sar4435
pharma
iph6101
cell
results
sanofi
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published:
2023-11-27
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.62%
|
O:
-0.36%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-1.77%
|
O:
1.04%
H:
0.17%
C:
0.11%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
0.0%
|
O:
2.07%
H:
1.21%
C:
1.21%
pharma
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
Published:
2023-11-14
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
1.97%
|
O:
0.68%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
6.61%
|
O:
6.61%
H:
9.39%
C:
6.61%
pharma
business
update
financial
results
Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Published:
2023-11-07
(Crawled : 08:00)
- biospace.com/
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
1.31%
|
O:
-1.32%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-6.92%
|
O:
-2.31%
H:
2.76%
C:
1.18%
pharma
conference
business
update
Innate Pharma Announces Its Participation to Upcoming November 2023 Investor Conferences
Published:
2023-10-27
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-11.93%
|
O:
-18.18%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-12.92%
|
O:
-15.73%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-1.63%
|
O:
-2.85%
H:
12.13%
C:
3.77%
pharma
Innate Pharma 2024 Financial Calendar
Published:
2023-10-19
(Crawled : 07:00)
- biospace.com/
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-13.89%
|
O:
-2.42%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-7.63%
|
O:
-8.78%
H:
15.06%
C:
0.0%
pharma
financial
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.